Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Substituting zanubrutinib for acalabrutinib with venetoclax
She would use zanubrutinib in place of acalabrutinib if needed, though prefers guideline‑based regimens for standard care.
Play episode from 29:31
Transcript
